Campbell Kyle
Overview
Explore the profile of Campbell Kyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henry A, Heather N, Kyle C, Gudex T, Webster D, Wilson C
N Z Med J
. 2025 Feb;
138(1610):60-73.
PMID: 40014772
Aims: Severe B12 deficiency is harmful to infants. This study describes the recent detection and treatment rates of antenatal and infant B12 deficiency in the Auckland-Northland region. Method: Regional laboratory...
2.
Nardi-Agmon I, Di Meo A, Lam L, Kyle C, Abdel-Qadir H, Amir E, et al.
JACC CardioOncol
. 2024 Sep;
6(4):608-611.
PMID: 39239330
No abstract available.
3.
Lam L, Kyle C
Ann Clin Biochem
. 2023 Aug;
61(2):122-132.
PMID: 37578158
Introduction: Macrotroponin is increasingly recognised as a cause of confusion in interpreting high-sensitivity cardiac troponin (hs-cTnI) results. In this study, we sought to evaluate two practical approaches to detecting macrotroponin....
4.
Lam L, Tse R, Gladding P, Kyle C
Clin Chem
. 2022 Aug;
68(10):1261-1271.
PMID: 35929566
Background: Macrotroponin is an important cause of discrepancy between current high-sensitivity cardiac troponin (hs-cTn) assays, however, its clinical significance is unclear. This study examined the effects of macrotroponin and repeat...
5.
Lam L, Hammarsten O, Kyle C
Clin Chem Lab Med
. 2022 Jan;
60(3):68-70.
PMID: 35007413
No abstract available.
6.
Lam L, Ha L, Heron C, Chiu W, Kyle C
Clin Chem Lab Med
. 2021 Sep;
59(12):1972-1980.
PMID: 34496163
Objectives: Macrotroponin is due to cardiac troponin (cTn) binding to endogenous cTn autoantibodies. While previous studies showed a high incidence of macrotroponin affecting cTnI assays, reports of macrotroponin T, particularly...
7.
Lam L, Ha L, Gladding P, Tse R, Kyle C
Pathology
. 2021 Jul;
53(7):860-866.
PMID: 34272050
Macrotroponin is a complex formed between endogenous cardiac troponin autoantibodies and circulating cardiac troponin (cTn). It is a recognised cause of discrepancy between current high sensitivity troponin (hs-cTn) assays; and...
8.
Musaad S, Chan G, Kyle C
N Z Med J
. 2020 Oct;
133(1523):16-28.
PMID: 33032300
Aims: To determine whether glycated haemoglobin (HbA1c) results from three commonly used platforms can be interpreted cumulatively and used interchangeably in individuals with common haemoglobinopathies. A secondary goal was to...
9.
Lam L, Aspin L, Heron R, Ha L, Kyle C
Clin Chem
. 2020 Feb;
66(3):445-454.
PMID: 32031592
Background: Despite well-described analytical effects of autoantibodies against cardiac troponin (cTn) I on experimental assays, no study has systematically examined their impact on cTn assays in clinical use. We determined...
10.
Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D
J Inherit Metab Dis
. 2019 Feb;
42(1):86-92.
PMID: 30740730
When screening for carnitine uptake disorder (CUD), the New Zealand (NZ) newborn screening (NBS) service identified infants as screen-positive if they had initial and repeat free carnitine (C0) levels of...